Status:
COMPLETED
Effect of a Dyadic Multisensory and Cognitive Stimulation Program for People With Dementia and Their Caregivers
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Hong Kong Young Women's Christian Association
Conditions:
Dementia
Carer Stress Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although multisensory and cognitive stimulation therapy was shown as an effective intervention in improving cognition and behavioral symptoms of people with dementia (PWD), it is not commonly found as...
Detailed Description
Background: Dementia becomes a major issue of worldwide concern. According to the World Alzheimer Report, the number of patients with dementia (PWD) worldwide was estimated at 46.8 million and it wil...
Eligibility Criteria
Inclusion
- People with dementia and their family caregiver will be recruited.
- The People with Dementia (PWD)
- Inclusion Criteria:
- Aged 65 or above who had been diagnosed with any type of dementia,
- Community-dwelling (i.e., non-institutionalized)
- Understand Cantonese and able to follow simple instructions
- Family Caregivers
- Inclusion Criteria:
- Aged 18 years or above;
- The blood or by-marriage relatives (e.g. spouses, siblings, children, and grandchildren) of a person who has been clinically diagnosed with dementia, regardless of its types and these relatives are taking up the caring responsibilities ranging from physical aids to emotional supports, in the form of transportation, financial assistance, personal hygiene, and decision-making.;
- Providing most of the daily care and support for PWD (daily contact for at least four hours); and
- Able to speak Cantonese
- Exclusion Criteria for PWD and their family caregivers:
- Diagnosed with a mental disorder such as bipolar disorder, schizophrenia, or depression; and/or,
- Currently taking anticonvulsants, or any kind of psychotropic drugs, and/or identified with a self-reported suicidal thought or drug abuse in the past 6 months.
Exclusion
Key Trial Info
Start Date :
November 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03803592
Start Date
November 30 2018
End Date
January 30 2022
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patrick Kor
Hong Kong, Hong Kong